This category covers the generation of proteins through recombinant DNA technology. It includes host selection, expression optimization, and purification techniques used in different areas of research
Recombinant protein technology emerged from a series of foundational discoveries in molecular biology during the mid-20th century. These began with the identification of DNA as the carrier of genetic information in the 1940s, followed by the one gene–one enzyme hypothesis by Beadle and Tatum, and culminated in Watson and Crick's 1953 model of DNA structure, aided by X-ray diffraction data from Rosalind Franklin.
Recombinant proteins fuel research and therapy. Biointron explains their design, production, and importance in biotechnology.
Recombinant proteins replicate natural proteins. Biointron reviews their applications in biotechnology, medicine, and therapeutic antibody development.
Recombinant proteins drive innovation in biotech. Biointron reviews how they are produced and applied in therapeutics, diagnostics, and scientific research.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



